Could your Child's genes hold the key to better asthma control?
NCT ID NCT03015610
Summary
This study tested if adjusting the dose of a common reflux medicine (lansoprazole) based on a child's genetic makeup could improve their asthma control. It involved 41 children aged 6-17 who had both asthma and mild reflux symptoms. Over six months, researchers compared asthma symptoms in children who received the gene-tailored dose against those who received a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Nemours Children's Specialty Care
Jacksonville, Florida, 32207, United States
Conditions
Explore the condition pages connected to this study.